Clinical trial
The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF: a Prospective, Multicenter Cohort Study
NCT07077811 is registered in ClinicalTrials.gov with Affiliated Hospital of Nantong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF: a Prospective, Multicenter Cohort Study
- Lead sponsor
- Affiliated Hospital of Nantong University
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- June 1, 2025
- Completion date
- June 1, 2028
- Enrollment
- 158 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation (af), cardiovascular diseases, heart failure, hfpef - heart failure with preserved ejection fraction